Union code relating to medicinal products for human use, and repealing Directive 2001/83/EC and Directive 2009/35/EC

Date: 10.04.2024 · Reference: A9-0140/2024

medicinal product innovation labelling public health cross-border dimension competitiveness market approval marketing standard pharmaceutical legislation security of supply regulatory policy European Medicines Agency patents licence quality of life
Overall Result: 495 For
495 For
57 Against
45 Abstention
270 Did not vote
Report Summary
Source: AI Summary with Mistral
  • Revision of the EU pharmaceutical codex after 20 years.
  • Focus on innovation, access and environmental sustainability.
  • Strengthening strategic autonomy in the health sector.
Amendments
Filter by Country
← Go back